Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Living Platform,Ltd. (7091.T)
JPY1,222.00
-9.00 (-0.73%)
JP JPX Healthcare Medical - Care Facilities
Address
15-4-38, Tsukisamu Higashi-Shijo 062-0054
Sapporo, JP
Sapporo, JP
CEO
Hirofumi Kaneko
Website
living-platform.com
IPO
2020-03-17
ISIN JP3974790002
Description
Established in 2011, Living Platform,Ltd. is a company based in Sapporo, Japan, that provides a range of services encompassing nursing care, childcare, and assistance for individuals with disabilities.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
JPY1,222.00
-9.00 (-0.73%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
9.5K
Beta
0.67
Float Shares
877.6K
Free Float %
19.6%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -14.33% | -10.25% | -12.20% | -3.42% | +10.35% | +7.01% | +13.80% | -0.62% | +28.41% | +11.88% | +11.88% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
1,222.00
Ratings Trend (MoM)
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
2.37
Grey zone
Piotroski F-Score
4 / 9
Average
MOAT Score
5 / 10
Developing
Composite Rating
B
Overall Score
3 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
5 / 5
High
ROA Score
4 / 5
High
D/E Score
1 / 5
Low
P/E Score
3 / 5
Medium
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Care Facilities: +10.2%+14.9% ★ Q1'26: +12.8% (vs Q1'25)
-
EPS growth Medical - Care Facilities: +19.2%+8.4% Q1'26: -41.0% (vs Q1'25)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%+0.8% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Medical - Care Facilities: +11.3%+2.0% Q1'26: +0.4% (vs Q1'25)
-
ROIC Medical - Care Facilities: +6.8%+4.7% Q1'26: +1.2% (vs Q1'25)
-
Share dilution Medical - Care Facilities: +0.0%+0.1% Q1'26: -0.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×7.17× Q1'26: 11.12× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|
| Revenue |
7.73B
est: 7.57B (+2.1%)
|
9.13B
est: 9.59B (-4.8%)
|
11.63B
est: 11.33B (+2.6%)
|
13.69B
est: 13.70B (0.0%)
|
16.66B
est: 16.64B (+0.2%)
|
19.20B
est: 19.40B (-1.0%)
|
22.04B
22.04B – 22.04B
+13.6% YoY
|
| EBITDA |
545.68M
est: 424.44M (+28.6%)
|
255.97M
est: 537.70M (-52.4%)
|
557.45M
est: 635.26M (-12.2%)
|
81.19M
est: 768.14M (-89.4%)
|
342.75M
est: 472.42M (-27.4%)
|
758.79M
est: 989.50M (-23.3%)
|
1.12B
1.12B – 1.12B
+13.6% YoY
|
| EBIT |
328.94M
est: 239.73M (+37.2%)
|
24.99M
est: 303.70M (-91.8%)
|
255.98M
est: 358.80M (-28.7%)
|
-242.77M
est: 433.85M (-156.0%)
|
-81.49M
est: 322.04M (-125.3%)
|
341.27M
est: 700.95M (-51.3%)
|
796.41M
796.41M – 796.41M
+13.6% YoY
|
| Net Income |
104.73M
est: 104.56M (+0.2%)
|
56.90M
est: 274.16M (-79.2%)
|
407.96M
est: 409.89M (-0.5%)
|
91.70M
est: 251.04M (-63.5%)
|
189.35M
est: 172.28M (+9.9%)
|
365.59M
est: 253.16M (+44.4%)
|
312.31M
312.31M – 312.31M
+23.4% YoY
|
| SGA |
699.78M
est: 668.75M (+4.6%)
|
748.14M
est: 847.21M (-11.7%)
|
863.58M
est: 1.00B (-13.7%)
|
1.52B
est: 1.21B (+25.4%)
|
1.53B
est: 1.47B (+3.9%)
|
1.60B
est: 1.72B (-7.3%)
|
1.96B
1.96B – 1.96B
+13.6% YoY
|
| EPS |
25.91
est: 23.37 (+10.9%)
|
12.68
est: 61.27 (-79.3%)
|
90.93
est: 91.60 (-0.7%)
|
20.62
est: 56.10 (-63.2%)
|
42.56
est: 38.50 (+10.5%)
|
82.15
est: 56.50 (+45.4%)
|
69.70
69.70 – 69.70
+23.4% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | B | 3/5 | 1/5 | 5/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-14 | B | 3/5 | 1/5 | 5/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-13 | B | 3/5 | 1/5 | 5/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-12 | B | 3/5 | 1/5 | 5/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-11 | B | 3/5 | 1/5 | 5/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-08 | B | 3/5 | 1/5 | 5/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-07 | B | 3/5 | 1/5 | 5/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-01 | B+ | 3/5 | 1/5 | 5/5 | 4/5 | 1/5 | 4/5 | 3/5 |
| 2026-04-30 | B+ | 3/5 | 1/5 | 5/5 | 4/5 | 1/5 | 4/5 | 3/5 |
| 2026-04-28 | B+ | 3/5 | 1/5 | 5/5 | 4/5 | 1/5 | 4/5 | 3/5 |
| 2026-04-27 | B+ | 3/5 | 1/5 | 5/5 | 4/5 | 1/5 | 4/5 | 3/5 |
| 2026-04-24 | B | 3/5 | 1/5 | 5/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-23 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-22 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-21 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-20 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-17 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-16 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
1.03B
OE per share TTM
299.85
Owner's Yield
17.43%
Maintenance CapEx ratio
447.12%
Maint CapEx / Avg PPE
34.7%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
385.1K
Shares Outstanding
4.48M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Hirofumi Kaneko | Chairperson & Chief Executive Officer | — | male |
| Ryusuke Hayashi | GM of Strategic Planning Hq. & GM of Business Collaboration Promotion Department and MD | — | male |
| Takase Kiichi | Head of Internal Audit | — | — |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 7091.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
